Literature DB >> 28561681

Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field.

Alexandru E Eniu1, Yehoda M Martei1, Edward L Trimble1, Lawrence N Shulman1.   

Abstract

The global burden of cancer incidence and mortality is on the rise. There are major differences in cancer fatality rates due to profound disparities in the burden and resource allocation for cancer care and control in developed compared with developing countries. The right to cancer care and control should be a human right accessible to all patients with cancer, regardless of geographic or economic region, to avoid unnecessary deaths and suffering from cancer. National cancer planning should include an integrated approach that incorporates a continuum of education, prevention, cancer diagnostics, treatment, survivorship, and palliative care. Global oncology as an academic field should offer the knowledge and skills needed to efficiently assess situations and work on solutions, in close partnership. We need medical oncologists, surgical oncologists, pediatric oncologists, gynecologic oncologists, radiologists, and pathologists trained to think about well-tailored resource-stratified solutions to cancer care in the developing world. Moreover, the multidisciplinary fundamental team approach needed to treat most neoplastic diseases requires coordinated investment in several areas. Current innovative approaches have relied on partnerships between academic institutions in developed countries and local governments and ministries of health in developing countries to provide the expertise needed to implement effective cancer control programs. Global oncology is a viable and necessary field that needs to be emphasized because of its critical role in proposing not only solutions in developing countries, but also solutions that can be applied to similar challenges of access to cancer care and control faced by underserved populations in developed countries.

Entities:  

Mesh:

Year:  2017        PMID: 28561681     DOI: 10.1200/EDBK_175251

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  5 in total

1.  Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries.

Authors:  Fabiola Valvert; Oscar Silva; Elizabeth Solórzano-Ortiz; Maneka Puligandla; Marcos Mauricio Siliézar Tala; Timothy Guyon; Samuel L Dixon; Nelly López; Francisco López; César Camilo Carías Alvarado; Robert Terbrueggen; Kristen E Stevenson; Yasodha Natkunam; David M Weinstock; Edward L Briercheck
Journal:  Blood Adv       Date:  2021-05-25

Review 2.  The dawn of vaccines for cancer prevention.

Authors:  Olivera J Finn
Journal:  Nat Rev Immunol       Date:  2017-12-27       Impact factor: 53.106

Review 3.  Medication overuse in oncology: current trends and future implications for patients and society.

Authors:  Stephen M Schleicher; Peter B Bach; Konstantina Matsoukas; Deborah Korenstein
Journal:  Lancet Oncol       Date:  2018-04       Impact factor: 41.316

4.  Program Planning to Develop Infrastructure for Cancer Care in Liberia.

Authors:  Ann Marie Beddoe; Wilhelmina Jallah; Bernice Dahn
Journal:  JCO Glob Oncol       Date:  2022-03

5.  Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana.

Authors:  Tara M Friebel-Klingner; Hari S Iyer; Doreen Ramogola-Masire; Lisa Bazzett-Matabele; Barati Monare; Alexander Seiphetlheng; Tlotlo B Ralefala; Nandita Mitra; Douglas J Wiebe; Timothy R Rebbeck; Surbhi Grover; Anne Marie McCarthy
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.